Rizvi Syed Ali-aamir
SEC CIK 1897621 · EDGAR
BoughtSold
Most active insiders at RCKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilson Martin | GC | — | $334.6K |
| 2 | Shah Gaurav | CEO, Dir | — | $285.6K |
| 3 | Militello John | See Remarks | — | $138.3K |
| 4 | Stevens Christopher James | COO | — | $128.3K |
| 5 | Chaudhuri Sarbani | See Remarks | — | $84.2K |
| 6 | Bjork Elisabeth | Dir | $34.4K | — |
| 7 | Schwartz Jonathan David | See Remarks | — | $7,584 |
| 8 | Fong Peter | Dir | — | — |
| 9 | Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| 10 | Malik Fady Ibraham | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-11 | RCKT | ROCKET PHARMACEUTICALS, INC. | Rizvi Syed Ali-aamir | Chief Medical Off | A - Grant | $0.00 | +62.0K | 407.9K | +18% | $0 |
| DM | 2025-10-08 | 2025-10-06 | RCKT | ROCKET PHARMACEUTICALS, INC. | Rizvi Syed Ali-aamir | Chief Medical Off | A - Grant | $0.00 | +345.9K | 283.0K | New | $0 |
| 2023-01-20 | 2023-01-19 | CRBU | Caribou Biosciences, Inc. | Rizvi Syed Ali-aamir | Chief Medical Off | S - Sale | $6.31 | -5,627 | 59.4K | -9% | -$35.5K | |
| D | 2022-01-25 | 2022-01-25 | CRBU | Caribou Biosciences, Inc. | Rizvi Syed Ali-aamir | Chief Medical Off | A - Grant | $0.00 | +60.0K | 65.0K | +1,200% | $0 |
Purchase Sale Sale after option exercise All abbreviations